5-Dec-2025
No headlines found.
No press releases found.
No news found.
Global X HealthTech ETF (HEAL) invests in companies transforming healthcare through cutting-edge technology. The fund targets four sub-themes AI-enabled drug discovery, smart medical devices, tech-enabled consumer healthcare, and healthcare analytics and software solutions. Companies in these areas harness advanced technologies to enhance patient care, streamline operations, and drive medical breakthroughs. By focusing on tech-driven innovation, HEAL seeks to provide exposure to firms shaping the future of healthcare. The Fund invests at least 80% of its total assets, plus borrowings for investment purposes (if any), in the securities of the Global X HealthTech Index (the "Underlying Index") and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the Underlying Index. The objective of the Global X HealthTech Index is to track the performance of companies involved in Healthcare Technology industry.
Global X Healthtech ETF trades on the NASDAQ stock market under the symbol HEAL.
As of December 5, 2025, HEAL stock price declined to $31.23 with 32,583 million shares trading.
HEAL has a market cap of $50.27 million. This is considered a Micro Cap stock.
HEAL support price is $30.80 and resistance is $31.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HEAL shares will trade within this expected range on the day.
